{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:49:38Z","timestamp":1792007378803,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011301","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000}}],"reference-count":145,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011301.pub2","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T19:14:31Z","timestamp":1625512471000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Botulinum toxin type A for facial wrinkles"],"prefix":"10.1002","volume":"2022","author":[{"given":"Cristina Pires","family":"Camargo","sequence":"additional","affiliation":[{"name":"Laboratory of Microsurgery and Plastic Surgery (LIM-04), School of Medicine; Universidade de S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[{"name":"Nottingham China Health Institute; The University of Nottingham Ningbo; Ningbo China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Specialised Medicine, Discipline of Dermatology; Universidade Federal do Piaui; Teresina Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Gemperli","sequence":"additional","affiliation":[{"name":"Department of Surgery, Discipline of Plastic Surgery; Universidade de S\u00e3o Paulo; S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria DC","family":"Tatini","sequence":"additional","affiliation":[{"name":"c\/o Cochrane Skin Group; The University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max K","family":"Bulsara","sequence":"additional","affiliation":[{"name":"Institute for Health Research; University of Notre Dame Australia; Fremantle Australia"},{"name":"School of Population and Global Health; The University of Western Australia; Perth Australia"},{"name":"Division of Surgery and Interventional Science; University College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Riera","sequence":"additional","affiliation":[{"name":"Cochrane Brazil Rio de Janeiro; Cochrane; Petr\u00f3polis Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD011301.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines","volume":"51","author":"Ascher","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.asj.2005.05.004","article-title":"Botulinum toxin A in the treatment of glabellar lines: scheduling the next injection","volume":"25","author":"Ascher","year":"2005","journal-title":"Aesthetic Surgery Journal"},{"issue":"10","key":"10.1002\/14651858.CD011301.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1524-4725.2009.01261.x","article-title":"Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study","volume":"35","author":"Ascher","year":"2009","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011301.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/asj\/sjw272","article-title":"Liquid formulation of abobotulinumtoxinA exhibits a favorable efficacy and safety profile in moderate to severe glabellar lines: a randomized, double-blind, placebo- and active comparator-controlled trial","volume":"38","author":"Ascher","year":"2018","journal-title":"Aesthetic Surgery Journal"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/asj\/sjz003","article-title":"Liquid formulation of abobotulinumtoxinA: A 6-month, phase 3, double-blind,randomized, placebo-controlled study of a single treatment, ready-to-use toxin for moderate-to-severe glabellar lines","volume":"40","author":"Ascher","year":"2020","journal-title":"Aesthetic Surgery Journal"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0006|cit6","unstructured":"Efficacy and safety of clostridium botulinum toxin type A to improve appearance of moderate to severe glabellar lines (BTX-A-HAC NG) clinicaltrials.gov\/ct2\/show\/NCT02353871"},{"issue":"2","key":"10.1002\/14651858.CD011301.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1524-4725.2006.32036.x","article-title":"Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids","volume":"32","author":"Beer","year":"2006","journal-title":"Dermatologic Surgery"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/DSS.0000000000001903","article-title":"Efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in adult subjects: results from 2 identical phase III studies","volume":"45","author":"Beer","year":"2019","journal-title":"Dermatologic Surgery"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/DSS.0000000000001903","article-title":"Efficacy and safety of prabotulinumtoxinA for the treatment of glabellar lines in adult subjects: results From 2 identical phase III studies","volume":"45","author":"Beer","year":"2019","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaad.2019.06.1313","article-title":"DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)","volume":"82","author":"Bertucci","year":"2020","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PRS.0000000000006327","article-title":"DaxibotulinumtoxinA for injection for the treatment of glabellar lines: results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2)","volume":"145","author":"Carruthers","year":"2020","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"12","key":"10.1002\/14651858.CD011301.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/j.1524-4725.2009.01235.x","article-title":"Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety","volume":"35","author":"Brandt","year":"2009","journal-title":"Dermatologic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"Carruthers","year":"2002","journal-title":"Journal of the American Academy of Dermatology."},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0014|cit14","first-page":"461","article-title":"A prospective, double-blind, randomized, parallel- group, dose- ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides","volume":"29","author":"Carruthers","year":"2003","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0015|cit15","first-page":"1089","article-title":"Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines","volume":"112","author":"Carruthers","year":"2003","journal-title":"Plastic and Reconstructive Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0016|cit16","first-page":"1","article-title":"One-year, randomised, multicenter, two-period study of the safety and efficacy of repeated treatments with botulinum toxin type A in patients with glabellar lines","volume":"7","author":"Carruthers","year":"2004","journal-title":"Journal of Clinical Research"},{"issue":"10","key":"10.1002\/14651858.CD011301.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00042728-200510000-00006","article-title":"Prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids","volume":"31","author":"Carruthers","year":"2005","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00042728-200504000-00007","article-title":"Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females","volume":"31","author":"Carruthers","year":"2005","journal-title":"Dermatologic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaad.2009.01.005","article-title":"A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy","volume":"60","author":"Carruthers","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD011301.pub2-BIB0020|cit20","first-page":"924","article-title":"A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes","volume":"8","author":"Carruthers","year":"2009","journal-title":"Journal of Drugs in Dermatology."},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011301.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1524-4725.2010.01705.x","article-title":"Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg\/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation","volume":"36","author":"Carruthers","year":"2010","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/dsu.12100","article-title":"Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines","volume":"39","author":"Carruthers","year":"2013","journal-title":"Dermatologic Surgery"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/DSS.0000000000000128","article-title":"Efficacy and safety of onabotulinumtoxinA for the treatment of crow\u2019s feet lines: a multicenter, randomized, controlled trial","volume":"40","author":"Carruthers","year":"2014","journal-title":"Dermatologic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/DSS.0000000000000357","article-title":"A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of repeated onabotulinumtoxinA treatments in subjects with crow's feet lines and glabellar lines","volume":"41","author":"Carruthers","year":"2015","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0025|cit25","unstructured":"Safety and efficacy study of botulinum toxin type A for the treatment of crow's feet lines and frown lines clinicaltrials.gov\/ct2\/show\/NCT01224015"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/DSS.0000000000001206","article-title":"Injectable daxibotulinumtoxinA for the treatment of glabellar lines: a phase 2, randomized, dose-ranging, double-blind, multicenter comparison with onabotulinumtoxinA and placebo","volume":"43","author":"Carruthers","year":"2017","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0027|cit27","unstructured":"Efficacy and safety of botulinum toxin type A for injection to treat glabellar lines clinicaltrials.gov\/ct2\/show\/NCT02303002"},{"issue":"12","key":"10.1002\/14651858.CD011301.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/DSS.0000000000001920","article-title":"Efficacy and safety of prabotulinumtoxin A and onabotulinumtoxin A for crow's feet A phase 3, multicenter, randomized, double-blind, split-face study","volume":"45","author":"Cheon","year":"2019","journal-title":"Dermatologic Surgery"},{"issue":"9","key":"10.1002\/14651858.CD011301.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1524-4725.2012.02456.x","article-title":"OnabotulinumtoxinA dose-ranging study for hyperdynamic perioral lines","volume":"38","author":"Cohen","year":"2012","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5935\/scd1984-8773.201681738","article-title":"Multicenter, prospective, comparative, randomized, double-blind clinical study comparing two botulinum toxin type A formulations registered in Brazil for the treatment of glabellar wrinkles","volume":"8","author":"Costa","year":"2016","journal-title":"Surgical and Cosmetic Dermatology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011301.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/j.1524-4725.2010.01795.x","article-title":"A double-blind, randomized, placebo-controlled health- outcomes survey of the effect of botulinum toxin type a injections on quality of life and self-esteem","volume":"36","author":"Dayan","year":"2010","journal-title":"Dermatologic Surgery"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/DSS.0000000000001612","article-title":"Phase 3 study of onabotulinumtoxinA distributed between frontalis, glabellar complex, and lateral canthal areas for treatment of upper facial lines","volume":"44","author":"De Boulle","year":"2018","journal-title":"Dermatologic Surgery"},{"issue":"1 Spec No","key":"10.1002\/14651858.CD011301.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1524-4725.2006.32325.x","article-title":"Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study","volume":"33","author":"Fagien","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011301.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/DSS.0000000000000265","article-title":"Optimal dosage of botulinum toxin type A for treatment of glabellar lines: efficacy and safety in a clinical trial","volume":"41","author":"Feng","year":"2015","journal-title":"Dermatologic Surgery"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD011301.pub2-BIB0035|cit35","first-page":"AB21","article-title":"A randomized, double blind, split-face comparison of Botox verses dysport for glabellar and forehead lines","volume":"66","author":"Firoz","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/dsu.12160","article-title":"A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint","volume":"39","author":"Hanke","year":"2013","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00266-008-9199-6","article-title":"A double-blind, randomized, placebo-controlled, two- dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects","volume":"32","author":"Harii","year":"2008","journal-title":"Aesthetic Plastic Surgery"},{"issue":"7","key":"10.1002\/14651858.CD011301.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-4632.2009.04071.x","article-title":"An open-label, randomized, 64-week study repeating 10- and 20-U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects","volume":"48","author":"Kawashima","year":"2009","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00266-017-0844-9","article-title":"Onabotulinumtoxina (botox) in the treatment of crow's feet lines in Japanese subjects","volume":"41","author":"Harii","year":"2017","journal-title":"Aesthetic Plastic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0040|cit40","unstructured":"BOTOX\u00ae in the treatment of upper facial lines in Japan clinicaltrials.gov\/ct2\/show\/NCT01797094"},{"issue":"12","key":"10.1002\/14651858.CD011301.pub2-BIB0041|cit41","first-page":"1356","article-title":"Full-face injections of variable total doses of abobotulinum toxin type A: A randomized, phase IV clinical trial of safety and efficacy","volume":"12","author":"Hexsel","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1097\/PRS.0b013e3181b5641b","article-title":"Evaluation of variable-dose treatment with a new U.S. botulinum toxin type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study","volume":"124","author":"Kane","year":"2009","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/DSS.0000000000000531","article-title":"A randomized, double-blind trial to investigate the equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for glabellar frown lines","volume":"41","author":"Kane","year":"2015","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011301.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13555-013-0033-y","article-title":"Triple-blind, prospective, internally controlled comparative study between AbobotulinumtoxinA and OnabotulinumtoxinA for the treatment of facial rhytids","volume":"3","author":"Kassir","year":"2013","journal-title":"Dermatology and Therapy"},{"issue":"10","key":"10.1002\/14651858.CD011301.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/DSS.0000000000000450","article-title":"Efficacy and safety of incobotulinumtoxina in the treatment of upper facial lines: results from a randomized, double-blind, placebo-controlled, phase iii study","volume":"41","author":"Kerscher","year":"2015","journal-title":"Dermatologic Surgery"},{"issue":"12","key":"10.1002\/14651858.CD011301.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jdv.12408","article-title":"Double-blind, randomized non-inferiority trial of a novel botulinum toxin a processed from the strain cbfc26, compared with onabotulinumtoxin a in the treatment of glabellar lines","volume":"28","author":"Kim","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/PRS.0000000000001032","article-title":"The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines","volume":"135","author":"Kim","year":"2015","journal-title":"Plastic and Reconstructive Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.toxicon.2012.07.152","article-title":"Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blinded, active controlled multicenter study","volume":"68","author":"Lee","year":"2013","journal-title":"Toxicon"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2006.07.006","article-title":"Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study","volume":"55","author":"Lowe","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1090820X11430685","article-title":"Prospective randomized comparison of onabotulinumtoxinA (Botox) and abobotulinumtoxinA (Dysport) in the treatment of forehead, glabellar, and periorbital wrinkles","volume":"32","author":"Michaels","year":"2012","journal-title":"Aesthetic Surgery Journal"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/14764172.2012.738913","article-title":"A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines","volume":"14","author":"Moers-Capri","year":"2012","journal-title":"Journal of Cosmetic and Laser Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/DSS.0000000000000220","article-title":"Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial","volume":"41","author":"Moers-Capri","year":"2015","journal-title":"Dermatologic Surgery"},{"issue":"1 Spec No","key":"10.1002\/14651858.CD011301.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","article-title":"A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose","volume":"33","author":"Monheit","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/DSS.0000000000002013","article-title":"Efficacy, safety, and subject satisfaction after abobotulinumtoxinA treatment for moderate to severe glabellar lines","volume":"46","author":"Monheit","year":"2020","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0055|cit55","unstructured":"Dysport in the treatment of glabellar lines in Chinese subjects clinicaltrials.gov\/ct2\/show\/NCT02450526"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0056|cit56","unstructured":"Efficacy and safety of botulinum toxin type A haemagglutinin complex next generation (BTX-A-HAC NG) in glabellar lines clinicaltrials.gov\/ct2\/show\/NCT02493946"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archfaci.2011.37","article-title":"An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA","volume":"13","author":"Nettar","year":"2011","journal-title":"Archives of Facial Plastic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archfaci.2011.1142","article-title":"Split-face double-blind study comparing the onset of action of onabotulinumtoxinA and abobotulinumtoxinA","volume":"14","author":"Yu","year":"2012","journal-title":"Archives of Facial Plastic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/DSS.0000000000001779","article-title":"OnabotulinumtoxinA for treatment of forehead and glabellar lines: subject-reported satisfaction and impact from phase 3 double-blind study","volume":"45","author":"Ogilvie","year":"2019","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/DSS.0000000000001883","article-title":"OnabotulinumtoxinA for simultaneous treatment of upper facial lines: subject-reported satisfaction and impact from a phase 3 study","volume":"46","author":"Rivkin","year":"2020","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/09546634.2013.769041","article-title":"Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A","volume":"25","author":"Lee","year":"2014","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.sap.0000123806.03865.4d","article-title":"Botox and collagen for glabellar furrows: advantages of combination therapy","volume":"52","author":"Patel","year":"2004","journal-title":"Annals of Plastic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/CCID.S41537","article-title":"Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study","volume":"6","author":"Rappl","year":"2013","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD011301.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/DSS.0000000000000424","article-title":"Subject satisfaction with onabotulinumtoxina treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure","volume":"41","author":"Rivers","year":"2015","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0065|cit65","first-page":"439","article-title":"The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment","volume":"8","author":"Rubin","year":"2009","journal-title":"Journal of Drugs in Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archderm.142.3.320","article-title":"Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region","volume":"142","author":"Rzany","year":"2006","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0067|cit67","unstructured":"Rzany BJ Ascher B Avelar RL Bergdahl J Bertucci V Bodokh I A multicenter, randomized, double-blind, placebo-controlled, single-dose, phase III, non-inferiority study comparing prabotulinumtoxinA and onabotulinumtoxinA for the treatment of moderate to severe glabellar lines in adult subjects Aesthetic Surgery Journal 10.1093\/asj\/sjz110"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD011301.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1524-4725.2010.01706.x","article-title":"Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines","volume":"36","author":"Sattler","year":"2010","journal-title":"Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/DSS.0000000000000626","article-title":"Efficacy and safety of onabotulinumtoxina treatment of forehead lines: a multicenter, randomized, dose-ranging controlled trial","volume":"42","author":"Solish","year":"2016","journal-title":"Dermatologic Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011301.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.toxicon.2018.11.255","article-title":"A head-to-head dose-ranging study of daxibotulinumtoxinA for injection in the treatment of glabellar lines: results of the BELMONT study","volume":"156","author":"Solish","year":"2018","journal-title":"Toxicon"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD011301.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/dsu.12072","article-title":"Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active- controlled multicenter study","volume":"39","author":"Won","year":"2013","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011301.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/ijd.12627","article-title":"Comparative trial of a novel botulinum neurotoxin type A versus onabotulinumtoxinA in the treatment of glabellar lines: a multicenter, randomized, double-blind, active-controlled study","volume":"54","author":"Won","year":"2015","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1524-4725.2009.01390.x","article-title":"Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study","volume":"36","author":"Wu","year":"2010","journal-title":"Dermatologic Surgery"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD011301.pub2-BIB0074|cit74","first-page":"AB80","article-title":"Botulinum toxin type A for the treatment of glabellar lines in Chinese subjects: a multicenter, double-blind, placebo-controlled trial","volume":"60","author":"Wu","year":"2009","journal-title":"Journal of the American Academy of Dermatology."},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e2079","DOI":"10.1097\/GOX.0000000000002079","article-title":"Efficacy of onabotulinumtoxinA for treatment of crow's feet lines in Chinese subjects","volume":"7","author":"Wu","year":"2019","journal-title":"Plastic and Reconstructive Surgery - Global Open"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0076|cit76","unstructured":"A prospective, open-label, multicenter, repeat-dose trial to investigate the safety and efficacy of NT 201 (incobotulinumtoxinA) in the combined treatment of upper facial lines (horizontal forehead lines, glabellar frown lines, and lateral periorbital lines) www.clinicaltrialsregister.eu\/ctr-search\/search?query=2014-003770-16"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/DSS.0000000000002165","article-title":"Repeated full-face aesthetic combination treatment with abobotulinumtoxinA, hyaluronic acid filler, and skin-boosting hyaluronic acid after monotherapy with abobotulinumtoxinA or hyaluronic acid filler","volume":"46","author":"Cartier","year":"2020","journal-title":"Dermatologic Surgery"},{"issue":"12","key":"10.1002\/14651858.CD011301.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1097\/DSS.0000000000001679","article-title":"Efficacy, safety, and subject satisfaction after abobotulinumtoxinA treatment of upper facial lines","volume":"44","author":"Hexsel","year":"2018","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/DSS.0000000000000646","article-title":"Prospective randomized split-face comparative study between topical botulinum toxin A surface application and local injection for crow's feet","volume":"42","author":"Mahmoud","year":"2016","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0080|cit80","unstructured":"Safety and efficacy study of repeat treatment with PurTox\u00ae botulinum toxin type A for frown lines between the eyebrows (PT-03b) clinicaltrials.gov\/ct2\/show\/NCT00752050"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0081|cit81","unstructured":"Safety and efficacy study of PurTox\u00ae botulinum toxin type A to treat frown lines between the eyebrows (PT-03a) clinicaltrials.gov\/ct2\/show\/NCT00752297"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0082|cit82","unstructured":"Safety and efficacy of azzalure\/dysport, restylane\/emervel filler and restylane skinbooster treatment clinicaltrials.gov\/ct2\/show\/NCT02297516"},{"issue":"8","key":"10.1002\/14651858.CD011301.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/DSS.0000000000000805","article-title":"A randomized, comparative study to evaluate the efficacy and safety of two injection volumes of abobotulinumtoxinA in treatment of glabellar lines","volume":"42","author":"Punga","year":"2016","journal-title":"Dermatologic Surgery"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD011301.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/dsu.12008","article-title":"Long-term results for incobotulinumtoxinA in the treatment of glabellar frown lines","volume":"39","author":"Rzany","year":"2013","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/PRS.0000000000002076","article-title":"Quantitative analysis of onabotulinumtoxinA, abobotulinumtoxinA, and incobotulinumtoxinA: a randomized, double-blind, prospective clinical trial of comparative dynamic strain reduction","volume":"137","author":"Wilson","year":"2016","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0086|cit86","first-page":"5033","article-title":"Combination therapy of botulinum toxin type A and hyaluronic acid filler for facial rejuvenation","volume":"11","author":"Zhang","year":"2018","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0087|cit87","unstructured":"Efficacy and safety of a new botulinum toxin type A for treatment of facial expression lines clinicaltrials.gov\/ct2\/show\/NCT01180348"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0088|cit88","unstructured":"Clinical trial to evaluate ANT-1207 in subjects with crow's feet clinicaltrials.gov\/ct2\/show\/NCT01358695"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0089|cit89","unstructured":"Safety and efficacy study of botulinum toxin type A to treat glabellar lines clinicaltrials.gov\/ct2\/show\/study\/NCT01485601"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0090|cit90","unstructured":"Comparison of escalating doses of incobotulinumtoxin A (Xeomin\u00ae) in the treatment of glabellar rhytids clinicaltrials.gov\/ct2\/show\/NCT01583478"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0091|cit91","unstructured":"To evaluate the safety and efficacy of Botulax\u00ae are not inferior to those of Botox\u00ae in the treatment of glabellar lines clinicaltrials.gov\/ct2\/show\/NCT01791920"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0092|cit92","unstructured":"Dose finding study in subjects with crow's feet clinicaltrials.gov\/ct2\/show\/NCT01951742"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0093|cit93","unstructured":"Safety and efficacy study of botulinum toxin for the treatment of glabellar frown lines clinicaltrials.gov\/ct2\/show\/NCT02236312"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0094|cit94","unstructured":"Botulinum toxin treatment of glabellar lines: efficacy and safety study I (BLESS I) clinicaltrials.gov\/ct2\/show\/NCT02677298"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0095|cit95","unstructured":"Botulinum toxin treatment of glabellar lines: efficacy and safety study II (BLESS II) clinicaltrials.gov\/ct2\/show\/NCT02677805"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0096|cit96","unstructured":"Efficacy and safety of DWP450 for the treatment of crows feet lines clinicaltrials.gov\/ct2\/show\/NCT02882893"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0097|cit97","unstructured":"A phase I\/II clinical trial to compare the safety and efficacy of HU-014 versus Botox\u00ae in subject with moderate to severe glabellar lines clinicaltrials.gov\/ct2\/show\/nct02961673"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0098|cit98","unstructured":"MEDITOXIN\u00ae in treatment of crow's feet line clinicaltrials.gov\/ct2\/show\/NCT03317574"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0099|cit99","unstructured":"The safety and efficacy study of Hutox versus Botox\u00ae in subject with moderate to severe glabellar lines clinicaltrials.gov\/ct2\/show\/nct03440671"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0100|cit100","unstructured":"MT10109L in the treatment of glabellar lines with or without concurrent treatment of lateral canthal lines clinicaltrials.gov\/ct2\/show\/NCT03721016"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0101|cit101","unstructured":"Safety and efficacy of abobotulinumtoxinA for the treatment of glabellar lines clinicaltrials.gov\/ct2\/show\/NCT03736928"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0102|cit102","unstructured":"Study to investigate the safety and duration of effect of different Botulinum Toxin A (NT 201) dose groups following the treatment of glabellar frown lines clinicaltrials.gov\/ct2\/show\/NCT03806933"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0103|cit103","unstructured":"The efficacy and safety of CUNOX\u00ae in patients with moderate to severe glabellar lines clinicaltrials.gov\/ct2\/show\/NCT03837561"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0104|cit104","unstructured":"Safety and efficacy study of ATGC-100 for the treatment of moderate to severe glabellar lines in adult subjects clinicaltrials.gov\/ct2\/show\/NCT03970876"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0105|cit105","unstructured":"Botulinum toxin treatment of glabellar lines: Efficacy and safety study III (BLESS III) (BLESS III) clinicaltrials.gov\/ct2\/show\/NCT03985982"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0106|cit106","unstructured":"A phase 1\/3 clinical trial to evaluate the safety and efficacy of HUTOX compared to Botox\u00ae in subjects with moderate to severe crow's feet lines clinicaltrials.gov\/ct2\/show\/NCT04081402"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0107|cit107","unstructured":"Clinical trial to evaluate the efficacy and safety of MBA-P01 in treatment of glabellar lines clinicaltrials.gov\/ct2\/show\/NCT04143815"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0108|cit108","unstructured":"Treatment of moderate to severe lateral canthal lines and glabellar lines alone or in combination (READY-3) clinicaltrials.gov\/ct2\/show\/NCT04247074"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0109|cit109","unstructured":"Treatment of moderate to severe glabellar lines (READY-1) clinicaltrials.gov\/ct2\/show\/NCT04249583"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0110|cit110","unstructured":"A phase I\/II randomized, double blind, active-controlled, single center clinical trial for evaluation of safety and efficacy of ATGC-110, an intramuscularly administered clostridium botulinum neurotoxin type A, in adult patients with moderate to severe glabellar frown lines clinicaltrials.gov\/ct2\/show\/NCT04281095"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0111|cit111","unstructured":"The American Society for Aesthetic Plastic Surgery 2016 Cosmetic Surgery National Data Bank Statistics www.surgery.org\/sites\/default\/files\/ASAPS-Stats2016.pdf"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0112|cit112","unstructured":"The American Society for Aesthetic Plastic Surgery Botulinum Toxin www.plasticsurgery.org\/cosmetic-procedures\/botulinum-toxin\/cost"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1468-3083.2010.03631.x","article-title":"International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) - Part 1: upper facial wrinkles","volume":"24","author":"Ascher","year":"2010","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"10","key":"10.1002\/14651858.CD011301.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.bjps.2012.04.016","article-title":"Botulinum neurotoxin A: a review","volume":"65","author":"Berry","year":"2012","journal-title":"Journal of Plastic, Reconstructive & Aesthetic Surgery"},{"issue":"8","key":"10.1002\/14651858.CD011301.pub2-BIB0115|cit115","first-page":"802","article-title":"A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A","volume":"29","author":"Carruthers","year":"2003","journal-title":"Dermatologic Surgery"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD011301.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1097\/PRS.0b013e31816de8d0","article-title":"Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations","volume":"121","author":"Carruthers","year":"2008","journal-title":"Plastic & Reconstructive Surgery"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011301.pub2-BIB0117|cit117","first-page":"S155","article-title":"A validated grading scale for forehead lines","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatologic Surgery"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011301.pub2-BIB0118|cit118","first-page":"S150","article-title":"A validated brow positioning grading scale","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatologic Surgery"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011301.pub2-BIB0119|cit119","first-page":"S173","article-title":"A validated grading scale for crow\u2019s feet","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatologic Surgery"},{"issue":"2 Spec no.","key":"10.1002\/14651858.CD011301.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1524-4725.2011.02251.x","article-title":"Validated assessment scales for the mid face","volume":"38","author":"Carruthers","year":"2012","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/dsu.12463","article-title":"Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies","volume":"40","author":"Cavallini","year":"2014","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00042728-200305000-00002","article-title":"Development of the facial lines treatment satisfaction questionnaire and initial results for botulinum toxin type A-treated patients","volume":"29","author":"Cox","year":"2003","journal-title":"Dermatologic Surgery"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD011301.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1097\/00006534-200310001-00007","article-title":"Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery","volume":"112","author":"Fagien","year":"2003","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"1 Spec No","key":"10.1002\/14651858.CD011301.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1524-4725.2006.32325.x","article-title":"Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study","volume":"33","author":"Fagien","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"6","key":"10.1002\/14651858.CD011301.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/PRS.0b013e31818dbfe3","article-title":"A comprehensive review of patient-reposted satisfaction with botulinum toxin type A for aesthetic procedures","volume":"122","author":"Fagien","year":"2008","journal-title":"Plastic & Reconstructive Surgery"},{"issue":"2 Spec no","key":"10.1002\/14651858.CD011301.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1524-4725.2011.02248.x","article-title":"Validated assessment scales for upper face","volume":"38","author":"Flynn","year":"2012","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaging.2012.11.001","article-title":"Designing \u2018older\u2019 rather than denying ageing: Problematizing anti-ageing discourse in relation to cosmetic surgery undertaken by older people","volume":"27","author":"Garnham","year":"2013","journal-title":"Journal of Aging Studies"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"E","DOI":"10.1038\/sj.bdj.2009.784","article-title":"Facial aesthetics: is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials","volume":"207","author":"Gadhia","year":"2009","journal-title":"British Dental Journal"},{"issue":"11","key":"10.1002\/14651858.CD011301.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/j.1524-4725.2012.02582.x","article-title":"OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines","volume":"38","author":"Glogau","year":"2012","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0130|cit130","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2021"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0131|cit131","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0132|cit132","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Review of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"2","key":"10.1002\/14651858.CD011301.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2133.2003.05436.x","article-title":"Reproducibility of a four-point clinical severity score for glabellar frown lines","volume":"149","author":"Honeck","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD011301.pub2-BIB0134|cit134","first-page":"1256","article-title":"Reproducibility of two four-point clinical severity scores for lateral canthal lines (crow's feet)","volume":"32","author":"Hund","year":"2006","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011301.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00266-016-0682-1","article-title":"Adverse events of botulinum toxin type A in facial rejuvenation: a systematic review and meta-analysis","volume":"40","author":"Jia","year":"2016","journal-title":"Aesthetic Plastic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1090820X12437784","article-title":"Development and validation of a new clinically-meaningful rating scale for measuring lateral canthal line severity","volume":"32","author":"Kane","year":"2012","journal-title":"Aesthetic Surgery Journal"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anplas.2006.11.007","article-title":"Botulinum toxin and the Face Recurve concept: decreasing resting tone and muscular regeneration","volume":"52","author":"Le Louarn","year":"2007","journal-title":"Annales de Chirurgie Plastique et Esthetique"},{"issue":"2 Spec no.","key":"10.1002\/14651858.CD011301.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1524-4725.2011.02247.x","article-title":"Validated assessment scales for the lower face","volume":"38","author":"Narins","year":"2012","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD011301.pub2-BIB0139|cit139","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan 5.4) 2020"},{"issue":"2 Spec no.","key":"10.1002\/14651858.CD011301.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1524-4725.2011.02252.x","article-title":"Validated composite assessment scales for the global face","volume":"38","author":"Rzany","year":"2012","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD011301.pub2-BIB0141|cit141","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001782.pub2","article-title":"Interventions for photodamaged skin","author":"Samuel","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2 Spec no","key":"10.1002\/14651858.CD011301.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1524-4725.2011.02253.x","article-title":"Validated assessment scale for neck volume","volume":"38","author":"Sattler","year":"2012","journal-title":"Dermatologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD011301.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"518e","DOI":"10.1097\/01.prs.0000475758.63709.23","article-title":"Global aesthetics consensus: botulinum toxin type A-evidence-based review emerging concepts, and consensus recommendations for aesthetic use, including updates on complications","volume":"137","author":"Sundaram","year":"2016","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"4","key":"10.1002\/14651858.CD011301.pub2-BIB0144|cit144","first-page":"113","article-title":"Factors influencing face aging. Literature review","volume":"13","author":"Sveikata","year":"2011","journal-title":"Stomatologija"},{"issue":"9","key":"10.1002\/14651858.CD011301.pub2-BIB0145|cit145","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011301","article-title":"Botulinum toxin for facial wrinkles","author":"Camargo","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T10:07:34Z","timestamp":1668420454000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011301.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":145,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011301.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]}}}